SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015289
Filing Date
2021-11-09
Accepted
2021-11-09 16:10:54
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20210930x10q.htm   iXBRL 10-Q 1413580
2 EX-10.1 omer-20210930xex10d1.htm EX-10.1 256901
3 EX-31.1 omer-20210930xex31d1.htm EX-31.1 10898
4 EX-31.2 omer-20210930xex31d2.htm EX-31.2 12101
5 EX-32.1 omer-20210930xex32d1.htm EX-32.1 8113
6 EX-32.2 omer-20210930xex32d2.htm EX-32.2 7664
7 GRAPHIC omer-20210930x10q006.jpg GRAPHIC 24818
8 GRAPHIC omer-20210930xex10d1001.jpg GRAPHIC 1956
  Complete submission text file 0001558370-21-015289.txt   7138977

Data Files

Seq Description Document Type Size
9 EX-101.SCH omer-20210930.xsd EX-101.SCH 37087
10 EX-101.CAL omer-20210930_cal.xml EX-101.CAL 56617
11 EX-101.DEF omer-20210930_def.xml EX-101.DEF 126250
12 EX-101.LAB omer-20210930_lab.xml EX-101.LAB 402682
13 EX-101.PRE omer-20210930_pre.xml EX-101.PRE 287803
14 EXTRACTED XBRL INSTANCE DOCUMENT omer-20210930x10q_htm.xml XML 1493902
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 211392232
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences